Apple is providing new options for setting default iPhone apps in iOS 18.4 across two categories, but one is exclusive to the ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

Apple is rolling out a sweeping software update packed with new tools, privacy-forward AI features, and expanded support for ...

Corcept Therapeutics' stock surged over 80% after its Phase 3 ROSELLA trial met its primary goal. See why we still consider ...

The EU is uniting electronics firms to tackle e-waste through the EECONE initiative. Discover how innovation is driving ...

Analysts say the judgment barring Marine Le Pen from running for public office plunges France into more political uncertainty.

European markets were higher Tuesday as global markets prepare for U.S. President Donald Trump’s trade tariffs to come into ...

OS Therapies Inc. ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial results ended ...

Apple released iOS 18.4, iPadOS 18.4, macOS 15.4, visionOS 2.4, tvOS 18.4, and watchOS 11.4. These releases represent an ...

Apple Intelligence has just been rolled out on a larger scale, internationally, with more languages  and locations included ...

The latest version of Apple's visionOS is available today, and it brings several upgrades to the Apple Vision Pro headset, ...

FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.